International Stem Cell Corporation
General ticker "ISCO" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $990.6K (TTM average)
International Stem Cell Corporation follows the US Stock Market performance with the rate: 30.3%.
Estimated limits based on current volatility of 5.0%: low 0.13$, high 0.15$
Factors to consider:
- Total employees count: 29 as of 2023
- US accounted for 84.1% of revenue in the fiscal year ended 2023-12-31
- Top business risk factors: Operating losses, Early stage company risks, Regulatory and compliance, Market acceptance, Cybersecurity threats
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.07$, 0.19$]
- 2025-12-31 to 2026-12-31 estimated range: [0.07$, 0.21$]
Financial Metrics affecting the ISCO estimates:
- Positive: with PPE of -2.6 at the end of fiscal year the price was low
- Positive: -3.60 < Operating profit margin, % of -0.74
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: negative Industry operating cash flow (median)
Short-term ISCO quotes
Long-term ISCO plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $8.18MM | $7.79MM | $9.09MM |
| Operating Expenses | $8.38MM | $8.45MM | $9.15MM |
| Operating Income | $-0.20MM | $-0.66MM | $-0.07MM |
| Non-Operating Income | $-0.14MM | $0.53MM | $-0.14MM |
| Interest Expense | $0.14MM | $0.14MM | $0.14MM |
| R&D Expense | $0.49MM | $0.51MM | $0.66MM |
| Income(Loss) | $-0.33MM | $-0.13MM | $-0.21MM |
| Profit(Loss)* | $-0.47MM | $-0.13MM | $-0.21MM |
| Stockholders Equity | $-4.52MM | $-4.19MM | $-3.93MM |
| Inventory | $1.38MM | $1.26MM | $1.15MM |
| Assets | $5.13MM | $5.39MM | $5.17MM |
| Operating Cash Flow | $0.33MM | $0.93MM | $0.01MM |
| Capital expenditure | $0.01MM | $0.08MM | $0.17MM |
| Investing Cash Flow | $-0.01MM | $-0.08MM | $-0.17MM |
| Financing Cash Flow | $0.25MM | $0.00MM | $-0.20MM |
| Earnings Per Share** | $-0.06 | $-0.02 | $-0.03 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.